1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Hemorrhagic Shock: new trials by email Literature Review of Hemorrhagic Shock trials Research Report on Hemorrhagic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2c Dose Comparison Study of MP4OX in Trauma MP4OX, Control - Trauma, Hemorrhagic Shock | Phase 2 | Withdrawn | Sangart | 2013-12-01 | 2013-10-31 |
Acidosis, Lactic (1) · Hemorrhage (1) · Shock, Hemorrhagic (1) · Wounds and Injuries (1)
Acid-Base Imbalance (1) · Acidosis (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Shock (1)
PEG-hemoglobin (1) · maleimide-polyethylene glycol-modified hemoglobin, MP4 (1) · polynitroxylated pegylated hemoglobin (1)
Sangart (1)
Australia (1) · Belgium (1) · Brazil (1) · France (1) · Germany (1) · Israel (1) · New Zealand (1) · Norway (1) · South Africa (1) · Switzerland (1) · United Kingdom (1)
Frank V. Booth, BCh, FACS (1) · Karim Brohi, MD (1)